ADD CONDITION

items per page

Blt 1

Last content change checked dailysee data sync status

Active ingredient
Benzocaine 20 g/100 g
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
Marketed in the U.S.
Since 2016
Label revision date
January 15, 2026
Active ingredient
Benzocaine 20 g/100 g
Other brand names
Drug class
Standardized Chemical Allergen
Dosage form
Ointment
Route
Topical
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Marketed in the U.S.
Since 2016
Label revision date
January 15, 2026
Manufacturer
CENTURA PHARMACEUTICALS INC
Registration number
M017
NDC root
70372-727

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

You can use this medication for the temporary relief of pain and itching. It is designed to help alleviate discomfort, making it easier for you to manage symptoms associated with various conditions. If you're experiencing pain or itching, this medication may provide the relief you need.

Uses

If you're experiencing pain and itching, this medication can provide you with temporary relief. It's designed to help soothe discomfort, allowing you to feel more comfortable in your daily activities. Whether it's due to minor skin irritations or other causes, this treatment aims to alleviate those bothersome sensations effectively.

Dosage and Administration

If you are an adult or a child who is at least two years old, you can apply this medication to the affected area up to three to four times a day. Make sure to follow this guideline to ensure the best results.

If your child is under two years old, it’s important to consult a physician (a medical doctor) before using this medication. They can provide the best advice tailored to your child's needs. Always remember to use the medication as directed for safety and effectiveness.

What to Avoid

There are no specific contraindications, controlled substance classifications, or risks of abuse, misuse, or dependence associated with this medication. This means that, based on the available information, there are no known reasons that would prevent you from using it safely.

However, it's always important to consult with your healthcare provider before starting any new medication to ensure it’s appropriate for your individual health needs. If you have any concerns or questions about this medication, don’t hesitate to reach out to your doctor or pharmacist for guidance.

Side Effects

When using this ointment, it's important to be aware of potential side effects. You should avoid contact with your eyes and any mucous membranes, and do not apply it to open or damaged skin. If your condition worsens or symptoms last longer than seven days, stop using the ointment and consult your doctor.

If you are pregnant or breastfeeding, please talk to your physician before using this product. Keep it out of reach of children, and if swallowed, contact Poison Control Center immediately. Additionally, do not use the ointment if you are allergic to any of its ingredients, and avoid applying it in large amounts, especially on raw or blistered areas.

Warnings and Precautions

This product is for external use only, so please avoid getting it in your eyes or on mucous membranes. It's important not to apply it to open or damaged skin. If your condition worsens or symptoms last longer than seven days, stop using the product and consult your doctor.

If you are pregnant or breastfeeding, make sure to talk to your physician before using this ointment. Keep it out of reach of children, and if it is swallowed, contact the Poison Control Center immediately. Additionally, do not use this product if you are allergic to any of its ingredients, and avoid using large amounts, especially on raw or blistered areas.

Overdose

If you or someone else has swallowed a medication and you suspect an overdose, it’s important to act quickly. Contact the Poison Control Center immediately for guidance. They can provide you with the necessary steps to take based on the specific situation.

Signs of an overdose can vary, but they may include unusual symptoms or changes in behavior. If you notice any concerning signs, don’t hesitate to seek immediate medical help. Your safety is the top priority, so getting professional assistance is crucial.

Pregnancy Use

If you are pregnant or breastfeeding, it is important to contact your physician before using this medication. Your healthcare provider can help you understand any potential risks and ensure that you make the safest choices for you and your baby. Always prioritize open communication with your doctor regarding any medications you may be considering during this time.

Lactation Use

If you are pregnant or breastfeeding, it’s important to talk to your doctor before using this medication. Your healthcare provider can help you understand any potential risks and ensure that you and your baby stay safe while breastfeeding. Always prioritize open communication with your physician regarding any medications you may consider during this time.

Pediatric Use

When using this medication for children, it's important to follow specific guidelines. For children aged two years and older, you can apply it to the affected area up to three to four times a day. However, if your child is under two years old, you should consult a physician (doctor) before using the medication to ensure it's safe for them.

Always keep in mind that proper usage is key to helping your child feel better while minimizing any risks. If you have any questions or concerns about the application or dosage, don't hesitate to reach out to your healthcare provider for guidance.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider for personalized advice. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

If you have kidney problems, it's important to know that there are no specific guidelines or dosage adjustments mentioned for your condition in the available information. This means that the usual recommendations for monitoring or safety considerations related to renal impairment (kidney issues) are not provided.

It's always best to discuss your individual situation with your healthcare provider, who can offer personalized advice and ensure that any medications you take are safe and appropriate for your kidney health.

Hepatic Impairment

If you have liver problems, it's important to know that the drug insert does not provide specific information about dosage adjustments, special monitoring, or precautions for your condition. This means that there are no tailored guidelines for how this medication may affect you if you have hepatic impairment (issues with liver function).

Always consult your healthcare provider for personalized advice and to discuss any concerns regarding your liver health and how it may relate to your treatment. They can help ensure that you receive the safest and most effective care.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications or tests you may be taking. While there are no specific drug interactions or laboratory test interactions noted for this medication, your healthcare provider can help ensure that everything you are taking works well together and is safe for you. Always share your complete list of medications and any health concerns to receive the best care possible.

Storage and Handling

To ensure the best performance of your product, store it in a cool, dry place where the temperature stays below 77°F (25°C). It's important to keep it away from direct sunlight, as exposure can affect its quality and effectiveness.

When handling the product, always do so with clean hands and in a clean environment to maintain its integrity. Following these simple storage and handling guidelines will help you use the product safely and effectively.

Additional Information

For adults and children aged two years and older, you should apply the medication to the affected area no more than three to four times a day. If the patient is under two years of age, it's important to consult a physician before use. There are no additional details available regarding laboratory tests, abuse potential, or patient counseling.

FAQ

What is the purpose of this drug?

This drug is used for the temporary relief of pain and itching.

How should I apply this drug?

Adults and children two years of age or older should apply it to the affected area no more than three to four times daily. For children under two years of age, consult a physician.

Are there any warnings I should be aware of?

Yes, this drug is for external use only. Avoid contact with eyes or mucus membranes, and do not apply to open or damaged skin.

What should I do if my condition worsens?

If your condition worsens or symptoms persist for more than seven days, discontinue use and consult a physician.

Can I use this drug if I am pregnant or breastfeeding?

If you are pregnant or breastfeeding, contact your physician prior to use.

What should I do if I accidentally swallow this drug?

Keep this drug out of reach of children. If swallowed, contact the Poison Control Center.

What should I do if I am allergic to an ingredient in this ointment?

Do not use the ointment if you are allergic to any ingredient in it.

How should I store this drug?

Store the drug below 77° F (25° C) and avoid direct sunlight.

Packaging Info

Below are the non-prescription pack sizes of Blt 1 (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blt 1.
Details

Drug Information (PDF)

This file contains official product information for Blt 1, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of pain and itching. It is intended for use in patients experiencing these symptoms due to various conditions.

Dosage and Administration

For adults and children aged two years and older, the recommended application frequency is three to four times daily to the affected area. It is important to ensure that the application does not exceed this frequency to avoid potential adverse effects.

For children under two years of age, it is advised to consult a physician prior to use to determine the appropriate course of action and ensure safety.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes or mucous membranes to prevent irritation or adverse reactions. The product should not be applied to open or damaged skin, as this may exacerbate the condition or lead to complications.

In cases where the condition worsens or symptoms persist for more than seven days, it is recommended to discontinue use and consult a physician for further evaluation and management.

Healthcare professionals should advise patients who are pregnant or breastfeeding to contact their physician prior to use to ensure safety for both the mother and child.

This product must be kept out of reach of children. In the event of accidental ingestion, immediate contact with a Poison Control Center is necessary to mitigate potential risks.

Patients should be cautioned against using the product if they have a known allergy to any ingredient in the ointment. Additionally, it is advised not to use the product in large quantities, particularly over raw surfaces or blistered areas, to avoid adverse effects.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and should not come into contact with the eyes or mucous membranes. It is contraindicated for application on open or damaged skin. In the event that the condition worsens or symptoms persist for more than seven days, patients are advised to discontinue use and consult a physician.

Pregnant or breastfeeding individuals should seek medical advice prior to using this product. It is essential to keep the product out of reach of children; if ingested, immediate contact with a Poison Control Center is recommended. Additionally, patients should not use the product if they are allergic to any of its ingredients. Caution is advised against using large quantities, especially over raw surfaces or blistered areas, to prevent potential adverse effects.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there are no known interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Blt 1 (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Blt 1.
Details

Pediatric Use

Pediatric patients aged two years and older may apply the medication to the affected area no more than three to four times daily. For children under two years of age, it is advised to consult a physician prior to use.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should contact their physician prior to using this medication. It is essential for healthcare providers to evaluate the potential risks and benefits associated with the use of this medication during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and caution is advised to ensure optimal fetal outcomes.

Lactation

Lactating mothers are advised to contact their physician prior to using this medication. There is no available data regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating patients.

Renal Impairment

Patients with renal impairment may not have specific dosage adjustments, special monitoring, or safety considerations outlined in the prescribing information. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in clinical trials for this medication. Consequently, there is no available information regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be warranted based on clinical judgment.

Overdosage

In the event of an overdosage, it is imperative to take immediate action. If the substance is ingested, healthcare professionals should contact the Poison Control Center for guidance.

Potential symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment of the patient's condition is essential.

Management of overdosage should be conducted in accordance with established protocols, which may include supportive care and symptomatic treatment as necessary. Continuous monitoring of the patient’s vital signs and clinical status is recommended to ensure appropriate interventions are implemented promptly.

Healthcare providers are advised to remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of the potential toxicological profile in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with improper access to the medication, ensuring that patients understand the necessity of safeguarding it in their home environment.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product below 77° F (25° C) to maintain its integrity and efficacy. Additionally, the product should be kept away from direct sunlight to prevent any potential degradation. Proper storage conditions are crucial for ensuring the quality and safety of the product throughout its shelf life.

Additional Clinical Information

For patients aged two years and older, the medication should be applied to the affected area no more than three to four times daily. For children under two years of age, it is advised to consult a physician prior to use. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Blt 1, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Blt 1, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.